ABT EBITDA Margin
Abbott Laboratories · EBITDA Margin
ABT EBITDA Margin
Latest reported24.31%period ending
ABT TTM EBITDA Margin (26.74% → 24.31%)
TTM ebitda margin
High-resolution chart · PNG
ABT ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| 24.3125% | |
| 25.6547% | |
| 27.0709% | |
| 26.9074% | |
| 26.9364% | |
| 26.3178% | |
| 25.826% | |
| 25.931% | |
| 25.5961% | |
| 25.8716% | |
| 26.4404% | |
| 25.1583% | |
| 24.9565% | |
| 25.8017% | |
| 27.233% | |
| 28.6387% | |
| 30.1352% | |
| 28.8112% | |
| 28.2275% | |
| 28.9023% | |
| 27.6489% | |
| 27.5269% | |
| 26.0142% | |
| 24.1116% | |
| 23.7661% | |
| 25.169% | |
| 24.79% | |
| 24.7265% | |
| 23.8759% | |
| 23.0284% | |
| 22.4998% | |
| 21.4723% | |
| 21.7582% | |
| 20.3902% | |
| 22.2928% | |
| 22.3005% | |
| 17.9354% | |
| 18.9571% | |
| 14.0268% | |
| 14.6658% | |
| 19.2012% | |
| 20.4188% | |
| 23.6119% | |
| 23.4336% | |
| 23.3254% | |
| 21.5229% | |
| 19.8259% | |
| 19.36% | |
| 18.4328% | |
| 16.8722% | |
| 17.8711% | |
| 16.1103% | |
| 14.4547% | |
| 14.2817% | |
| 13.5051% | |
| 16.4007% | |
| 17.1965% | |
| 20.6312% | |
| 22.58% | |
| 22.5619% | |
| 24.3945% | |
| 24.2329% | |
| 25.2803% | |
| 25.7601% | |
| 28.4568% | |
| 29.2499% | |
| 31.8645% | |
| 33.6443% | |
| 31.7461% | |
| 31.9361% | |
| 29.2921% | |
| 27.4018% | |
| 26.8324% | |
| 25.4673% | |
| 25.4699% | |
| 24.3095% | |
| 24.5205% | |
| 22.4292% | |
| 22.6929% | |
| 23.6481% | |
| 23.4285% | |
| 25.6247% | |
| 25.6889% | |
| 25.5611% | |
| 27.123% | |
| 27.6539% | |
| 26.9858% | |
| 26.9902% | |
| 25.6693% | |
| 21.7267% | |
| 22.3969% | |
| 21.6199% | |
| 22.671% | |
| 26.2249% | |
| 27.228% | |
| 27.8619% | |
| 27.2329% | |
| 27.6629% | |
| 26.972% | |
| 27.9014% |